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Objectives: To compare the evaluation and management of pediatric cutaneous abscess patients at 
three different emergency department (ED) settings.
Method: We conducted a retrospective cohort study at two academic pediatric hospital EDs, a 
general academic ED and a community ED in 2007, with random sampling of 100 patients at the 
three academic EDs and inclusion of 92 patients from the community ED. Eligible patients were ≤18 
years who had a cutaneous abscess. We recorded demographics, predisposing conditions, physical 
exam findings, incision and drainage procedures, therapeutics and final disposition. Laboratory 
data were reviewed for culture results and antimicrobial sensitivities. For subjects managed as 
outpatients from the ED, we determined where patients were instructed to follow up and, using 
electronic medical records, ascertained the proportion of patients who returned to the ED for further 
management. 
Result: Of 392 subjects, 59% were female and the median age was 7.7 years. Children at academic 
sites had larger abscesses compared to community patients, (3.5 versus 2.5 cm, p=0.02). Abscess 
incision and drainage occurred in 225 (57%) children, with the lowest rate at the academic pediatric 
hospital EDs (51%) despite the relatively larger abscess size. Procedural sedation and the collection 
of wound cultures were more frequent at the academic pediatric hospital and the general academic 
EDs. Methicillin-resistant Staphylococcus aureus (MRSA) prevalence did not differ among sites; 
however, practitioners at the academic pediatric hospital EDs (92%) and the general academic ED 
(86%) were more likely to initiate empiric MRSA antibiotic therapy than the community site (71%), 
(p<0.0001). At discharge, children who received care at the community ED were more likely to be 
given a prescription for a narcotic (23%) and told to return to the ED for ongoing wound care (65%). 
Of all sites, the community ED also had the highest percentage of follow-up visits (37%). 
Conclusion: Abscess management varied among the three settings, with more conservative 
antibiotic selection and greater implementation of procedural sedation at academic centers and 
higher prescription rates for narcotics, self-referrals for ongoing care and patient follow-up visits at 
the community ED. [West J Emerg Med. 2011;12(2):159-167.]
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INTRODUCTION
Concurrent with the emergence of Methicillin-resistant 
Staphylococcus aureus (MRSA) as a community pathogen, the 
incidence of skin and soft tissue infections has rapidly 
increased over the past decade.1-3 Since many skin and soft 
tissue infections, in particular skin abscesses, require urgent 
evaluation for potential surgical management and antibiotic 
therapy, emergency departments (EDs) receive a large number 
of visits for these infections, with children comprising a 
significant proportion of patients.4-9 Since ED care for 
pediatric patients is often provided in varied settings, ranging 
from the community setting to academic pediatric EDs, the 
management of pediatric skin abscesses has the potential to 
vary greatly based on the site of emergency care.10-12 
While evidence-based consensus guidelines can result in 
improved patient care, few currently exist for the management 
of cutaneous abscesses.13 This is further complicated by 
differences in routine care of adult and pediatric cutaneous 
abscesses, such as wound packing following incision and 
drainage, which has come into question in pediatric abscesses, 
and the use of routine wound cultures for bacterial 
surveillance.14-16  In addition, oligoanalgesia may complicate 
ED abscess care, particularly in the pediatric population.17,18  A 
common approach to abscess drainage includes local 
anesthesia; however, its use is questionable owing to the lower 
pH within the abscess cavity, which may reduce the 
effectiveness of lidocaine.14,19 As a result, local anesthesia, 
systemic analgesics and procedural sedation are variably used 
in different practice settings, although these differences have 
not been previously described.18 
Given the potential for highly variable clinical 
management, we initiated this investigation to examine 
practice patterns for skin abscess across three different 
emergency care settings: two academic children’s hospital 
EDs, a general academic ED and a community ED. We sought 
to compare these differences for three important aspects of 
care for skin abscesses: (1) procedural and antimicrobial 
therapies, (2) rates of wound culture and MRSA prevalence 
and (3) provision of analgesia.  
METHODS 
Study Design
This was a retrospective cohort study of children who 
presented to the ED for evaluation of a skin abscess. 
Study Setting and Population
Eligible subjects included children ≤18 years, diagnosed 
with a cutaneous abscess in one of four participating EDs 
between January 1 and December 31, 2007. Our goal was to 
focus on children with routine skin abscesses. To this end, we 
excluded children who presented with an isolated pilonidal or 
genital abscess, as these infections frequently involve 
consultation and management by a subspecialist. We also 
excluded patients with isolated paronychial infections since 
management is relatively standard, involving a minor drainage 
procedure and also because the causative organisms are 
typically oral rather than skin flora. The study was approved 
by each participating site’s institutional review board.
Of the four participating study centers, The Children’s 
Hospital of Philadelphia and St. Christopher’s Hospital for 
Children are dedicated academic, tertiary care pediatric 
hospitals with an approximate annual ED census of 82,000 
and 58,000 respectively. Cooper University Hospital is an 
academic center that provides care to both adults and children. 
This center has a nested pediatric ED located within the main 
(general academic) ED, where approximately 12,500 children 
are evaluated annually by fellowship-trained pediatric 
emergency physicians (EP) from 9 AM to 1 AM, and general 
EPs for the remaining eight hours. Our Lady of Lourdes 
Hospital, the fourth center, is a community ED, receiving 
9,000 pediatric visits per year. Children are cared for by 
board-certified EPs and nurse practitioners, none of whom are 
subspecialty trained pediatric healthcare providers. 
We acquired study data using computerized billing and 
data entry systems and identified potential subjects at each 
participating center using International Classification of 
Diseases, Ninth Revision codes consistent with skin infections 
(680.0–686.9). We reviewed medical records to identify 
patients who presented with a cutaneous abscess. A random 
selection of 100 patients from each of the three academic 
centers and 92 abscess patients from the community ED 
comprised the study cohort. We achieved the random selection 
of children from the academic centers using a random number 
generator (http://www.random.org).
Study Protocol
Data Abstraction Incorporated recommended protocols 
for chart review research, including case selection protocols, 
abstractor training and monitoring, and the use of standardized 
data abstraction forms.20 To ensure data quality, each site 
underwent a training period where 10 patient medical records 
were abstracted by both the originating site and the primary 
site. We compared these data forms and discussed and 
resolved any discrepancies (<1% of all data) before actual 
data collection was initiated. Each site had a primary data 
abstractor who was blinded to the goals of this investigation. 
Demographics, predisposing conditions,1, 21 physical exam 
findings, incision and drainage procedures, therapeutics (e.g. 
antibiotics, warm compresses), and final disposition were 
recorded. Laboratory data were reviewed for culture results 
and antimicrobial sensitivities. For subjects managed as 
outpatients from the ED, we determined where patients were 
instructed to follow up (pediatrician versus ED) and, using 
electronic medical records, ascertained the proportion of 
patients who returned to the ED for further management. 
Statistical Analysis
Normally distributed data are presented using summary 
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statistics with means ± standard deviation. Non-parametric 
data are presented as medians with interquartile ranges 
(IQR). We compared patient characteristics and patient 
management at three ED settings, academic pediatric EDs, a 
general academic ED and a community ED. For comparisons 
of categorical variables, we used Fisher’s exact and χ2 tests, 
where appropriate. We performed comparisons between 
the three settings using one-way analysis of variance for 
parametric data and the Kruskal-Wallis test for non-parametric 
data. Comparisons between two settings (i.e. the three 
academic sites versus the community site) were made using 
Student’s t-test for continuous variables. Significance was set 
at p ≤0.05. We analyzed data using SPSS version 15.0 (SPSS, 
Inc., Chicago, Il).
RESULTS
Patient Characteristics
A total of 392 patients were included in this cohort; data 
were available for all 392 (100%) eligible subjects. The study 
population consisted of 230 (59%) girls, 186 (47%) black and 
90 (23%) Hispanic children. The median age was 7.7 years 
(IQR: 2 to 15 years), with a bimodal distribution: 103 (26%) 
children between one and two years and 68 (17%) children 
16-17 years. Age differed among sites, with a younger patient 
population presenting to the children’s hospital EDs (median 
age 4.8 years; IQR: 1.7 to 13.8 years), older children at the 
community site (median age 8.4 years; IQR: 2.7 to 16.1 
years), and the oldest group at the general academic ED 
(median age 12.4 years; IQR: 3.4 to 16.6 years), p= 0.007. We 
present other patient characteristics, including co-morbidities, 
prior and family history of skin infections, in Table 1.
Compared to the community ED, children who presented 
to centers with dedicated pediatric EPs (the two academic 
pediatric hospital EDs and the general academic ED) had 
larger mean abscess size (3.5 ±2.4 cm versus 2.5 ±1.7cm; 
p=0.02). Over half of subjects, 216 (55%), underwent incision 
and drainage of their abscess in the ED. Nine additional 
children, all of whom presented to the academic pediatric 
hospital EDs, underwent incision and drainage in the operating 
room. Median age of these patients was 1.4 years (Range: 
5 months to 10.5 years). Mean abscess size was smallest in 
patients who did not undergo incision and drainage (2.8 ±2 
cm), larger in those who underwent ED-based procedures (3.5 
±2.4 cm) and largest in those who went to the operating room 
(5.4 ±3.5cm) (p=0.01). (Table 2). 
Culture Rates and Antimicrobial Sensitivities
Wound cultures were more commonly obtained at the 
children’s hospital and general academic EDs. MRSA was the 
most common organism isolated at all three study sites, 
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Table	1. Patient characteristics for academic pediatric, general academic pediatric and community emergency department (ED).
Characteristic Academic	Pediatric	
Hospital	ED
(n=200)
General	Academic	
Pediatric	ED
(n=100)
Community	ED
(n=92)
All	Patients
(n=392)
Female, n, % 114, 57% 61, 61% 55, 60% 230, 59%
Predisposing conditions
  History of prior abscess 55, 28% 34, 34% 16, 17% 105, 27%
  In contact with prior abscess patient 39, 20% 26, 26% 7, 8% 72, 18%
  Attend daycare (children <5 years) 17 of 101, 17% 4 of 30, 13% 4 of 35, 11% 25 of 166, 15%
  Hospitalized in past 30 days 13, 7% 3, 3% 4, 4% 20, 5%
Most common abscess sites 
  Lower extremity  50, 25% 42, 42% 29, 32% 121, 31%
  Buttock  51, 26% 21, 21% 22, 24% 94, 24%
  Abdomen 16, 8% 17, 17% 11, 12% 44, 11%
  Face 23, 12% 6, 6% 9, 10% 38, 10%
  Upper extremity 22, 11% 8, 8% 7, 8% 37, 9%
  Axilla  13, 7% 9, 9% 4, 4% 26, 7%
  Groin 14, 7% 5, 5% 5, 5% 24, 6%
Multiple abscesses at presentation 59, 30% 31, 31% 7, 8% 97, 25%
Surrounding cellulitis*  168, 84% 21, 21% 16, 17% 205, 52%
Presence of fever (≥38° Celsius)†  41, 21% 11, 11% 13, 14% 65, 17%
Hospitalized 48 , 24% 0 10, 11% 58, 15%
* If noted in the medical record that there was an area of cellulitis surrounding the abscess
† Temperature measured rectally in children <5 years and orally if ≥5 years.Volume XII, no. 2  :  May 2011    162  Western Journal of Emergency Medicine
ranging between 61-76%. MRSA prevalence did not 
significantly differ among EDs, nor did the rates of 
Methicillin-sensitive Staphylococcus aureus (MSSA) [Table 
2]. Of the non-MRSA/MSSA organisms, the most common 
isolates were coagulase negative Staphylococcus aureus 
(n=6); Proteus mirabilis (n=5), group A beta hemolytic 
streptococcus (n=3), and Pseudomonas aeruginosa (n=3). 
Antimicrobial sensitivities were obtained for the 138 
MRSA isolates. In all three practice settings, there was 100% 
susceptibility to trimethoprim-sulfamethoxazole and 97-
100% susceptibility to vancomycin. Linezolid susceptibility, 
tested only at the academic pediatric hospital EDs and at 
the community ED, was 100%. Cindamycin sensitivity was 
variable: 96% for the academic pediatric hospital EDs, 98% 
for the general academic ED and 80% for the community ED. 
Outpatient Instructions
At discharge, outpatient antibiotics were routinely 
prescribed at all sites, with practitioners at the academic 
pediatric hospital EDs prescribing empiric coverage for 
MRSA in the highest proportion of patients (Table 3). 
Instructions or prescriptions for eradication therapy were 
only provided at the academic pediatric hospital and the 
general academic EDs and included mupirocin ointment 
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Table	2.	Medical management and culture results at three pediatric care settings.
Medical	management Academic	Pediatric	
Hospital	ED
(n=200)
General	Academic	
Pediatric	ED
(n=100)
Community	ED	
(n=92)
P-value*
Underwent incision and drainage in ED, n, % 92, 46% 74, 74% 50, 54% < 0.0001
  Infiltrated anesthetic (lidocaine) 23 of 92, 25%  22 of 74, 30% 34 of 50, 68% < 0.0001
  Topical anesthetic cream 53 of 92, 58% 53 of 74, 72% 0 < 0.0001
  Procedural sedation used 26 of 92, 28% 24 of 74, 32% 6 of 50, 12% 0.04
  Packing placed in abscess cavity 16 of 92, 17% 39 of 74, 53% 25 of 50, 50% < 0.0001
Wound culture obtained† 126 of 156, 81% 70 of 89, 79% 18 of 63, 29% < 0.0001 
Organisms obtained at culture    
   MRSA  74 of 126, 59% 53 of 70, 76% 11 of 18, 61%  0.06
   MSSA  28 of 126, 22% 17 of 70, 24% 5 of 18, 28%  0.85
   Other organism(s)  24 of 126, 19%  0 2 of 18, 11%  0.0005
*χ2 used to compare patient management and organism characteristics at the three settings. 
†Wound culture percentages reflect only those patients who had a spontaneously draining abscess or underwent incision and drainage 
of their abscess, including in the operating room.
ED, emergency department; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus aureus
Table	3.	Discharge instructions and follow up at three pediatric care settings.
Medical	management Academic	Pediatric	
Hospital	ED
(n=152)
General	Academic	
Pediatric	ED
(n=100)
Community	ED	
(n=82)
P-value
Adjuvant antibiotics given at discharge, n, % 148, 97% 89, 89% 76, 93% 0.05
Empiric coverage for MRSA* 140, 92% 86, 86% 58, 71% <0.0001
  Trimethoprim-sulfamethoxazole 34 of 140, 24% 63 of 86, 73% 57 of 58, 98% <0.0001
  Clindamycin 106 of 140, 76% 23 of 86, 27% 1 of 58, 2% <0.0001
Eradication therapy recommended† 14, 9% 23, 23% 0 <0.0001
Advised to return to ED for follow-up 8, 5% 34, 34% 53, 65% <0.0001
Patients who returned to the ED for 
follow up wound care/packing change
20, 13% 35, 35% 30, 37% <0.0001
*Empiric antibiotic coverage for MRSA included oral trimethoprim/sulfamethoxazole or clindamycin. Antibiotics used that did not have 
MRSA coverage included: Cephalexin (n=13), Augmentin (n=6), Amoxicillin (n=5), Doxycycline, (n=2), Tetracycline (n=2), and Cipro-
floxacin (n=1)
†Eradication therapy using mupirocin ointment, hibiclens/chlorhexidine washes or bleach baths
ED, emergency department; MRSA, methicillin-resistant Staphylococcus aureusWestern Journal of Emergency Medicine   163  Volume XII, no. 2  :  May 2011
(n=35) and chlorhexidine baths (n=20) [Table 3]. Follow-
up recommendations also varied by site: academic pediatric 
hospital EDs were the most likely to refer patients back to 
their primary care providers. In contrast, the community ED 
instructed the majority of patients to return to the ED for 
follow up (Table 3). The highest follow-up rates were at the 
general academic and the community EDs. Of children who 
returned for follow up, nine at the two academic pediatric 
hospital EDs, three at the general academic ED and five at the 
community ED, had an unchanged or worsening presentation. 
Based on electronic admission data and subsequent review of 
individual medical records, 10 patients originally discharged 
from the ED were admitted to the hospital within 30 days of 
their initial visit for worsening of their original abscess. One 
child was admitted to one of the children’s hospitals, six were 
admitted to the general academic hospital and three were 
admitted to the community hospital.
Procedural Sedation and Analgesia
Assessment and treatment of pain differed among study 
sites. Although the community ED was the least likely to 
provide procedural sedation for abscess incision and drainage 
or use a topical anesthetic for pain control, practitioners at 
the community ED were the most likely to use infiltrated 
anesthesia prior to incision and drainage and to provide 
patients with oral pain medication. For the procedural sedation 
procedures conducted at the three academic centers (academic 
pediatric hospital and general academic EDs), a narcotic 
(fentanyl or morphine) was only used in two (2%) [academic 
pediatric hospital EDs] and 10 (14%) [general academic ED] 
patients. Ketamine was used in 31 (19%), midazolam in 35 
(21%), and propofol in eight (5%) of the three academic center 
patients. Provision of and instructions for the use of analgesics 
at discharge also differed between the three settings, with the 
general academic and the community EDs most frequently 
providing analgesic instructions and prescriptions (Table 4).
Age as a Factor Influencing Outcomes
Given the relatively younger patient population served by 
the academic pediatric hospital EDs, we were concerned that 
this patient subset may have influenced our results. To address 
this potential confounder, we excluded children two years and 
under and conducted selected analyses on the older subjects. 
These findings are presented in Table 5. 
DISCUSSION
In this study we describe the current presentation, 
bacteriology, sedation and analgesia practices and therapeutic 
strategies for pediatric cutaneous abscesses in three different 
ED settings. Prior studies of other conditions have 
demonstrated differences in patient characteristics and specific 
aspects of medical management between pediatric and general 
EDs; however, ours is the first to examine practice differences 
for pediatric abscesses among varying sites of emergency 
care.22,23
Medical management of patients differed among the 
academic pediatric hospital, the general academic and the 
community EDs. Abscess incision and drainage rates were 
higher in our four sites (55%) than previously described, with 
the highest rate in the general academic ED.11 Use of packing 
was nearly 2.5 times higher in the general academic and in the 
community EDs when compared to the academic pediatric 
hospital EDs. This difference may be due to provider 
preference, and neither method is considered superior to the 
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Table	4.	Pain assessment and treatment at three pediatric care settings. 
Characteristic Academic	Pediatric	
Hospital	ED
(n=200)
General	Academic	
Pediatric	ED
(n=100)
Community	ED	
(n=92)
P-Value
Pain assessed at triage, n, % 134, 67% 87, 87% 67, 73% 0.001
Mean pain score* 2.1 ±3.4 3.8 ±4.1 4.8 ± 3.5 0.003
Pain relievers given during ED visit
  Acetaminophen  13, 7% 4, 4% 6, 7% 0.66
  Ibuprofen 14, 7% 13, 13% 22, 24% <0.0001
  Oral narcotic 16, 8% 14, 14% 20, 22% 0.004
  Topical anesthetic† 57 of 92, 62% 54 of 74, 73% 0  <0.0001
  Infiltrated anesthetic (lidocaine)‡ 23 of 92, 25%  22 of 74, 30% 34 of 50, 68% <0.0001
Discharged with any pain medication   38 of 152, 25% 64, 64% 35 of 82, 43% <0.0001
Discharged with a narcotic pain medication   7 of 152, 5% 9, 9% 19 of 82, 23% <0.0001
*Triage pain scale of 1-10 completed for 63 academic pediatric hospital ED patients, 12 general academic ED patients and 28 commu-
nity ED patients. The remaining scores were either using the Wong Baker Faces scale or a descriptive assessment.
†Topical anesthetic use is only reported for patients who underwent an incision and drainage procedure. 
‡Infiltrated anesthetic was only used in incision and drainage patients.
ED, emergency departmentVolume XII, no. 2  :  May 2011    164  Western Journal of Emergency Medicine
other. Packing is theorized to prevent the wound margins from 
closing and forming a potential dead space, and periodic 
removal of packing is considered to provide gentle 
debridement of necrotic tissue.14 These theoretical benefits, 
however, have never been scientifically demonstrated, and a 
recent investigation demonstrated no significant difference in 
the need for a second intervention in adults who underwent 
packing of their abscess (17%) compared to those who did not 
(20%).15 An alternative reason for reduced packing rates at 
dedicated children’s hospitals is that abscess patients are 
routinely referred back to their pediatricians for ongoing care. 
Most pediatricians are not familiar or comfortable with the 
management of a packed wound, and, upon encountering one, 
may refer the patient back to the ED for ongoing wound 
management.
We also demonstrated differences in wound culture rates 
for pediatric skin abscesses. The academic pediatric hospital 
EDs and the general academic ED almost routinely obtained 
wound cultures, whereas the community ED obtained them 
only one third of the time. The community ED practice is 
discordant with recommendations from the Center for Disease 
Control, which encourages clinicians to collect specimens for 
culture and antimicrobial susceptibility testing from all 
patients with purulent skin lesions.24 Recently, however, the 
use of routine culturing has been questioned, with some EPs 
suggesting that unless the patient appears systemically ill or is 
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immunocompromised, simple incision and drainage without 
routine antimicrobial susceptibility testing or therapy should 
suffice.15,16 Two additional concerns regarding all-inclusive 
routine culturing, are whether it is appropriate to conduct such 
testing when the results will minimally (or not at all) alter 
patient management, and, whether it is appropriate for the 
individual patient to bear the cost of a test for perceived public 
health benefit.25 
Although overall MRSA prevalence was higher in our 
cohort than previously described, MRSA prevalence in the 
community ED most closely approximated rates reported in 
the literature.10,11,26 The routine use of antibiotics was 
somewhat unexpected, since only about half of the patients in 
our sample had a surrounding cellulitis documented in their 
medical record, an indication for antimicrobial therapy in the 
setting of a draining cutaneous abscess.16 There are several 
reasons why practitioners at the academic pediatric hospital 
and the general academic EDs were more likely to initiate 
empiric therapy for MRSA than the practitioners at the 
community ED. Given the tertiary care centers at which they 
practice, pediatric specialists are more likely to encounter 
children at higher risk for complications due to 
immunosuppression or comorbid factors. Alternatively, the 
high rates of MRSA prevalence may have influenced adjuvant 
outpatient therapy. Lastly, pediatric EM healthcare providers 
may be more likely to encounter life-threatening infections 
Table	5.	Medical management, culture results and pain control in children >2 years at three pediatric care settings.
Medical	management Academic	Pediatric	
Hospital	ED
(n=200)
General	Academic	
Pediatric	ED
(n=100)
Community	ED	
(n=92)
P-value*
Underwent incision and drainage in ED, n, % 61, 46% 62, 72% 45, 59% 0.001
  Infiltrated anesthetic (lidocaine) 19 of 61, 31%  20 of 62, 32%  30 of 45, 67% 0.0002
  Topical anesthetic cream  37of 61, 61%  43 of 62, 69% 0 < 0.0001
  Procedural sedation used  18 of 61, 30% 21 of 62, 34%  5 of 45, 11% 0.03
  Packing placed in abscess cavity  13 of 61, 21%  33 of 62, 53%  22 of 45, 49% < 0.0001
Wound culture obtained† 74 of 95, 78% 61 of 74 , 82% 12 of 56, 21% < 0.0001 
Organisms obtained at culture    
   MRSA   38 of 74, 51% 42 of 61, 69%  7 of 12, 58%  0.12
   MSSA   18 of 74, 24%  14 of 61, 23%  4 of 12, 33%  0.75
   Other organism(s)  18 of 74, 24%  0  1 of 12, 8%  0.0001
Adjuvant antibiotics given at discharge 111 of 113, 98% 76 of 86, 88% 64 of 70, 91% 0.02
Empiric coverage for MRSA 103 of 113, 91% 73 of 86, 85% 49 of 70, 70% 0.0008
Pain assessed at triage 134, 67% 87, 87% 67, 73% 0.001
Discharged with any pain medication   28 of 113, 25% 56 of 86, 65% 30 of 70, 43% <0.0001
Discharged with a narcotic pain medication   7 of 113, 6% 9 of 86, 11% 16 of 70, 23% <0.0001
*χ2 used to compare patient management and organism characteristics at the three settings. 
†Wound culture percentages reflect only those patients who had a spontaneously draining abscess or underwent incision and drainage 
of their abscess, including in the operating room
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due to community associated-MRSA (CA-MRSA), due to 
referrals and transfers of such children to their highly 
specialized practice settings. This may also have lowered their 
thresholds for administering antibiotics for uncomplicated skin 
abscesses.27-29
Nevertheless, the high rate of empiric antimicrobial 
therapy at all three practice settings is not consistent with the 
standard of care for uncomplicated abscess management, 
which remains incision and drainage.16 With the emergence of 
MRSA, this practice was re-examined in an adult population, 
where over 90% of patients experienced a clinical cure after 
undergoing incision and drainage and receiving a placebo.30 
Similar observations are documented in children who were 
discharged after their incision and drainage without antibiotics 
or on agents ineffective against MRSA.12,31,32 The results of a 
recent randomized controlled trial in children provides 
additional evidence that antimicrobial therapy is not required 
for the resolution of uncomplicated abscesses after incision 
and drainage.33 At three months, there was no difference 
between placebo and antibiotic treatment with respect to new 
abscess formation.33 At this time, it is unknown if CA-MRSA-
associated life-threatening infections and fatalities are related 
to prior or current cutaneous abscesses.34 Until this is 
demonstrated, the routine use of antimicrobial agents for 
uncomplicated, draining cutaneous abscesses remains 
questionable.16
We noted differences in the use of procedural sedation and 
analgesia among the sites of care as well. Topical anesthetics 
and procedural sedation for abscess drainage were more 
routinely employed in the academic pediatric hospital and 
the general academic EDs, whereas lidocaine infiltration 
was more common at the community site. These differences 
may be due to several factors. The mean abscess size in the 
community sample was approximately one centimeter smaller 
as compared to mean abscess size at the other sites. A smaller 
abscess may have lent itself to more effective local anesthesia. 
In contrast, procedural sedation may have been deemed 
necessary for the larger abscesses which were encountered at 
the other three sites. At discharge, the provision of analgesics 
(or instructions for the parent to provide the child with an 
analgesic medication) was also the lowest at the academic 
pediatric EDs. In contrast, the community ED had the highest 
rates of oral narcotic medication use during the ED visit and 
also at discharge. Our findings demonstrate that the need for 
acute pain control appears to be recognized across practice 
settings, yet improvements in pain assessment and outpatient 
pain management are still needed. These therapeutic 
oversights suggest that oligoanalgesia in the pediatric abscess 
population remains an issue at academic pediatric hospital, 
general academic and community EDs.
LIMITATIONS
Because we identified study subjects using billing data 
from each site, it is possible that potential subjects were 
missed, owing to errors in coding. Additionally, all data were 
obtained via medical record review, thus subjecting the study 
to information bias from missing data elements. The academic 
pediatric hospital EDs provided care to children who were 
younger than those who presented to the general academic and 
the community EDs, which may have had some influence on 
practitioners’ evaluation and management of pediatric abscess 
patients. We respectfully counter that age was not a primary 
factor in practice patterns, since the differences we noted in 
the use of procedural sedation and topical anesthetics for 
drainage procedures, abscess packing, antibiotic 
administration and selection, the assessment of pain at triage, 
and recommendations for follow up and for outpatient pain 
control remained even after limiting the analyses to children 
over two years of age. 
We were also unable to differentiate if MRSA abscesses 
were from community or hospital-associated strains. Our 
intention was to be inclusive of routinely evaluated cutaneous 
abscesses, not to focus on MRSA specifically. Cultures were 
not obtained in all cases of cutaneous abscesses, so our report 
of MRSA prevalence rates may not be accurate, although 
wound cultures were among the practices we wished to assess. 
While not a primary objective of this investigation, we did 
attempt to assess outcomes. These efforts were limited, due 
to the retrospective nature of this investigation. To maximize 
our ability to identify adverse outcomes, such as revisits 
to the ED and hospitalization, we conducted electronic ED 
visits, admissions and medical record reviews. Given that the 
four sites were all within a circumscribed geographic area, 
we are confident that the majority of patients who may have 
worsened during the 30-day window would have presented to 
one of the four sites and, therefore, would have been captured 
by our review. Pain scores were not consistently documented 
and only available for older children. Thus, the mean pain 
scores we reported may not accurately represent the level 
of pain in children at each site. Lastly, there were only four 
sites that participated in one metropolitan area, with only 
one general academic pediatric ED and one community ED, 
limiting the generalizability of our results. 
CONCLUSION
The results of our study demonstrate that the management 
of pediatric skin abscesses vary greatly by site of care. 
Community ED practitioners are more likely to use local 
anesthesia and wound packing but less likely to routinely 
obtain wound cultures. Academic pediatric hospital and 
general academic EDs, often staffed with pediatric emergency 
trained physicians, were more likely to use procedural 
sedation during ED management and send cultures after 
drainage procedures. Discharge practices also differed 
between sites. Practitioners at academic pediatric hospital EDs 
were more likely to refer patients back to their pediatrician, 
whereas at the community ED, and less so for the general 
academic ED, patients were instructed to return for ongoing 
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care. Outpatient pain management was highest at the general 
academic ED and practitioners at the community ED were the 
most likely to prescribe a narcotic pain reliever. Our findings 
highlight the differences in abscess management across 
emergency care settings, and reflect the lack of consensus 
regarding therapy for pediatric skin abscess. Dissemination of 
current research findings and subsequent standardization of 
care across settings could result in consistent and improved 
care for pediatric abscesses. As best evidence practices 
continue to develop, translation of this knowledge should be 
targeted at academic children’s hospital, general academic, 
and community EDs. 
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